title: Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer.
authors.forename: M
authors.initials: M
authors.lastname: Mahjoubi
authors.forename: J
authors.initials: J
authors.lastname: Kattan
authors.forename: J P
authors.initials: JP
authors.lastname: Droz
authors.forename: I
authors.initials: I
authors.lastname: Philippot
authors.forename: P
authors.initials: P
authors.lastname: Pautier
authors.forename: A
authors.initials: A
authors.lastname: Boutan-Laroze
authors.forename: M
authors.initials: M
authors.lastname: Azab
authors.forename: C
authors.initials: C
authors.lastname: Theodore
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D014747:Vinblastine; D002955:Leucovorin; D005472:Fluorouracil; D007069:Ifosfamide